These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 17342657

  • 1. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK, Ricks MO, Forman MS, Jabs DA, Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Clin Infect Dis; 2007 Apr 01; 44(7):1001-8. PubMed ID: 17342657
    [Abstract] [Full Text] [Related]

  • 2. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ, Charonis AC, Holland GN, Narayanan R, Kulkarni AD, Yu F, Boyer DS, Engstrom RE, Kuppermann BD, Southern California HIV/Eye Consortium.
    Ophthalmology; 2006 Apr 01; 113(4):683.e1-8. PubMed ID: 16581428
    [Abstract] [Full Text] [Related]

  • 3. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK.
    Am J Ophthalmol; 2005 Jun 01; 139(6):1028-34. PubMed ID: 15953432
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 01; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 5. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Jan 01; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 6. The prognosis of CMV retinitis among patients with AIDS in Serbia.
    Dujić M, Jevtović Dj, Salemović D, Ranin J, Brmbolić B, Djurković-Djaković O.
    Biomed Pharmacother; 2008 Sep 01; 62(7):443-7. PubMed ID: 18243635
    [Abstract] [Full Text] [Related]

  • 7. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Rudent A, Lantz O, Lecointe D, Furlan V, Delfraissy JF, Offret H.
    J Fr Ophtalmol; 1998 Oct 01; 21(8):567-76. PubMed ID: 9833222
    [Abstract] [Full Text] [Related]

  • 8. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A, Moe AA, Miller MJ, Wagar EA, Bruckner DA, Holland GN.
    Ophthalmology; 1999 Jan 01; 106(1):133-41. PubMed ID: 9917794
    [Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR, Jabs DA.
    Herpes; 2007 Dec 01; 14(3):66-71. PubMed ID: 18371289
    [Abstract] [Full Text] [Related]

  • 10. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R, Arama V, Paraschiv S, Streinu-Cercel A, Oţelea D, Munteanu D, Iosipenco M, Chiotan C, Benea OE, Mărdărescu M, Rădulescu M, Hristea A, Ungurianu R, Aramă SS, Cercel AS, Călin R, Băicuş C.
    Rom J Intern Med; 2008 Dec 01; 46(4):305-11. PubMed ID: 19480296
    [Abstract] [Full Text] [Related]

  • 11. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA, Studies of Ocular Complications of AIDS Researh Group.
    Ophthalmology; 2003 May 01; 110(5):987-95. PubMed ID: 12750102
    [Abstract] [Full Text] [Related]

  • 12. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct 01; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 13. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S, Badelon I, Chaine G.
    J Fr Ophtalmol; 1998 Jan 01; 21(1):34-41. PubMed ID: 9834898
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, Buhles W.
    J Infect Dis; 1999 Jun 01; 179(6):1352-5. PubMed ID: 10228054
    [Abstract] [Full Text] [Related]

  • 15. Ganciclovir implants: one year later.
    Cadman J.
    GMHC Treat Issues; 1997 Jun 01; 11(4/5):3-6. PubMed ID: 11364375
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S, Ochoa C, Carballal G, Zala C, Cahn P, Brunet R, Salomón H, Videla C.
    J Clin Virol; 2004 Jul 01; 30(3):271-5. PubMed ID: 15135748
    [Abstract] [Full Text] [Related]

  • 17. The high-dose, alternate-week intravitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapy.
    Yutthitham K, Ruamviboonsuk P.
    J Med Assoc Thai; 2005 Nov 01; 88 Suppl 9():S63-8. PubMed ID: 16681054
    [Abstract] [Full Text] [Related]

  • 18. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
    Grzywacz M, Deayton JR, Bowen EF, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    J Med Virol; 1999 Nov 01; 59(3):323-8. PubMed ID: 10502264
    [Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache P.
    Arch Ophthalmol; 1996 Jul 01; 114(7):809-14. PubMed ID: 8660163
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis.
    Jabs DA, Martin BK, Forman MS, Ricks MO, Cytomegalovirus Retinitis and Viral Resistance Research Group.
    J Infect Dis; 2005 Aug 15; 192(4):640-9. PubMed ID: 16028133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.